Cardlytics Inc. has announced that its newly appointed Chief Financial Officer, David Evans, has been granted 1,000,000 restricted stock units under the company’s 2022 Inducement Plan. Half of the units will vest on February 1, 2027, with the remaining 50% vesting quarterly over the following 12 months, contingent on Evans’ continued service with Cardlytics through each vesting date.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardlytics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260116071716) on January 16, 2026, and is solely responsible for the information contained therein.
Comments